Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
about
Retinoblastoma genetics in India: From research to implementation.Epidemiology and Rb1 gene of retinoblastoma.Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaThe genomic landscape of retinoblastoma: a review.Management of retinoblastoma in children: current status.Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population.Retinoblastoma, the visible CNS tumor: A review.
P2860
Q35663105-79A42245-462E-4C14-AB5D-31A937B1CF78Q35923816-69040B1C-0CCC-40F2-8165-76BA6F41E151Q37146786-4408BF0E-59F7-404F-AA20-5B34BA8122B2Q38179069-BD07AA86-78B4-4A55-9B79-E74709815B82Q38368017-187EE405-0A0A-4574-A0D8-D604F17FAFF9Q43061710-EEADDA92-8621-4A21-9681-B0A3BD4B5771Q48288706-CBC978A5-BFE3-4F1B-BDEC-A2E1CB565705
P2860
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@en
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@nl
type
label
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@en
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@nl
prefLabel
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@en
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@nl
P2093
P50
P1476
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
@en
P2093
Diane Rushlow
Esteban M Abella
Helen S L Chan
James Williams
John J Doyle
Paul Babyn
William Halliday
P356
10.1016/J.TRSL.2010.05.009
P577
2010-06-25T00:00:00Z